Summit Therapeutics (SMMT) Earnings Date & Reports

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SMMT is expected to report earnings to fall 25.79% to -27 cents per share on November 11

Summit Therapeutics SMMT Stock Earnings Reports

Q3'26

Est.

$-0.28

Q2'26

Missed

by $0.09

Q1'26

Missed

by $0.04

Q4'25

Missed

by $0.31

Q3'25

Beat

by $0.04

The last earnings report on July 23 showed earnings per share of -37 cents, missing the estimate of -28 cents. With 4.51M shares outstanding, the current market capitalization sits at 10.90B.

View a ticker or compare two or three

SMMT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days